Fisher & Paykel Healthcare Corporation Limited
FSPKFOTCHealthcare● Active
$22.52
+$1.97(+9.59%)
Market Cap$13.2B
P/E Ratio—
52W High$25.69
52W Low$16.35
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
FSPKF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 26, 2026EPS Actual
$0.25
Est. $0.24 · +4.0%
Revenue
$0.71B
Est. $0.68B · +4.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 26, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 3-Quarter EPS Beat Streak
FSPKF reports quarterly as a OTC-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 26, 2026 | $0.24 | $0.25 | +4.0% | $0.71B | $0.68B | +4.5% |
| ▲ Q4 FY2025 | Nov 25, 2025 | $0.20 | $0.21 | +5.2% | $0.64B | $0.62B | +2.4% |
| ▲ Q2 FY2025 | May 27, 2025 | $0.20 | $0.35 | +75.1% | $0.71B | $0.61B | +17.3% |
| ▼ Q4 FY2024 | Nov 27, 2024 | $0.17 | $0.16 | -5.5% | $0.59B | $0.60B | -2.3% |
| ▼ Q2 FY2024 | May 28, 2024 | $0.16 | $0.03 | -83.6% | $0.56B | $0.56B | +0.4% |
| ▲ Q3 FY2023 | Sep 29, 2023 | $0.10 | $0.11 | +4.3% | $0.49B | $0.48B | +1.9% |
| — Q1 FY2023 | Mar 31, 2023 | $0.16 | $0.17 | +0.8% | $0.56B | $0.55B | +2.0% |
| ▲ Q3 FY2022 | Sep 29, 2022 | $0.09 | $0.09 | +5.2% | $0.40B | $0.38B | +4.7% |
Q2 FY2026
May 26, 2026Beat
EPS Actual
$0.25
EPS Est.
$0.24
EPS Surpr.
+4.0%
Revenue
$0.71B
Q4 FY2025
Nov 25, 2025Beat
EPS Actual
$0.21
EPS Est.
$0.20
EPS Surpr.
+5.2%
Revenue
$0.64B
Q2 FY2025
May 27, 2025Beat
EPS Actual
$0.35
EPS Est.
$0.20
EPS Surpr.
+75.1%
Revenue
$0.71B
Q4 FY2024
Nov 27, 2024Miss
EPS Actual
$0.16
EPS Est.
$0.17
EPS Surpr.
-5.5%
Revenue
$0.59B
Q2 FY2024
May 28, 2024Miss
EPS Actual
$0.03
EPS Est.
$0.16
EPS Surpr.
-83.6%
Revenue
$0.56B
Q3 FY2023
Sep 29, 2023Beat
EPS Actual
$0.11
EPS Est.
$0.10
EPS Surpr.
+4.3%
Revenue
$0.49B
Q1 FY2023
Mar 31, 2023
EPS Actual
$0.17
EPS Est.
$0.16
EPS Surpr.
+0.8%
Revenue
$0.56B
Q3 FY2022
Sep 29, 2022Beat
EPS Actual
$0.09
EPS Est.
$0.09
EPS Surpr.
+5.2%
Revenue
$0.40B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2025 | $1.1B | $1.1B | $1.1B | 1 |
| Q2 FY2025 | $1.3B | $1.3B | $1.3B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 26, 2026 | +4.0% | $20.55 | $20.55 | +0.00% |
| ▲ Q4 FY2025 | Nov 25, 2025 | +5.2% | $20.56 | $20.56 | +0.00% |
| ▲ Q2 FY2025 | May 27, 2025 | +75.1% | $20.70 | $20.70 | +0.00% |
| ▼ Q4 FY2024 | Nov 27, 2024 | -5.5% | $20.20 | $20.20 | +0.00% |
| ▼ Q2 FY2024 | May 28, 2024 | -83.6% | $16.14 | $16.43 | +1.80% |
| ▲ Q3 FY2023 | Sep 29, 2023 | +4.3% | $12.70 | $12.70 | +0.00% |
| ▲ Q1 FY2023 | Mar 31, 2023 | +0.8% | $15.22 | $15.22 | +0.00% |
| ▲ Q3 FY2022 | Sep 29, 2022 | +5.2% | $11.00 | $10.93 | -0.64% |
Q2 FY2026+0.00%
Report Date
May 26, 2026
EPS Beat/Miss
+4.0%
Price Before
$20.55
Price After
$20.55
Q4 FY2025+0.00%
Report Date
Nov 25, 2025
EPS Beat/Miss
+5.2%
Price Before
$20.56
Price After
$20.56
Q2 FY2025+0.00%
Report Date
May 27, 2025
EPS Beat/Miss
+75.1%
Price Before
$20.70
Price After
$20.70
Q4 FY2024+0.00%
Report Date
Nov 27, 2024
EPS Beat/Miss
-5.5%
Price Before
$20.20
Price After
$20.20
Q2 FY2024+1.80%
Report Date
May 28, 2024
EPS Beat/Miss
-83.6%
Price Before
$16.14
Price After
$16.43
Q3 FY2023+0.00%
Report Date
Sep 29, 2023
EPS Beat/Miss
+4.3%
Price Before
$12.70
Price After
$12.70
Q1 FY2023+0.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
+0.8%
Price Before
$15.22
Price After
$15.22
Q3 FY2022-0.64%
Report Date
Sep 29, 2022
EPS Beat/Miss
+5.2%
Price Before
$11.00
Price After
$10.93
Avg Beat Reaction-0.11%
Avg Miss Reaction+0.90%
Beat Rate6 / 8 quarters
Largest Move+1.80% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: FSPKF ends December
Fisher & Paykel Healthcare Corporation Limited (FSPKF) most recently reported earnings on May 26, 2026 for Q2 FY2026, posting EPS of $0.25 — beating the analyst consensus of $0.24 by +4.0%. FSPKF has beaten EPS estimates for 3 consecutive quarters. The next FSPKF earnings date is expected around September 1, 2026.
Each quarter, investors track FSPKF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. FSPKF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
FSPKF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
FSPKF earnings · 5 questionsFisher & Paykel Healthcare Corporation Limited's next earnings report is expected around September 1, 2026. FSPKF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; FSPKF historically reports after market close (AMC).
FSPKF earnings datewhen is FSPKF earningsFSPKF next earnings datewhen does FSPKF report earningsFSPKF earnings calendar
▸ Source: FMP · Fisher & Paykel Healthcare Corporation Limited SEC filings · US GAAP · Fisher & Paykel Healthcare Corporation Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026